8-K: Bayview Faces Nasdaq Delisting, Appeals Decision

Bayview Acquisition Corp received a new non-compliance notice from Nasdaq and will appeal its delisting determination at a hearing on March 31, 2026.

Summary

• Bayview Acquisition Corp received a written notice from Nasdaq on February 19, 2026, regarding the Staff's determination to delist the company's securities.
• The company submitted an application on December 16, 2025, to transfer its listing from The Nasdaq Global Market to The Nasdaq Capital Market, believing it would help cure market value and minimum public holders deficiencies.
• A hearing before a Nasdaq Hearings Panel is scheduled for March 31, 2026, at 11:00 a.m. Eastern Time to appeal the delisting determination.
• On March 19, 2026, the company received another notice of non-compliance with Nasdaq Listing Rule 5450(b)(2)(B) (PHS Rule), requiring a minimum of 1,100,000 publicly held shares.
• The company will present its views on the PHS Rule deficiency at the upcoming hearing.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development, given the formal delisting determination and the new non-compliance notice, which collectively indicate significant operational and regulatory challenges for the company.

Positives

• The company believes that transferring its listing to The Nasdaq Capital Market, if approved, will better position it to cure existing market value and minimum public holders deficiencies.
• The company has timely requested a hearing to appeal the delisting determination.

Negatives

• Nasdaq determined to delist the company's securities.
• The company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(B), requiring a minimum of 1,100,000 publicly held shares.
• There is no assurance that the Transfer Application to The Nasdaq Capital Market will be approved.
• There is no assurance that the company will be able to regain compliance with Nasdaq listing rules or that the appeal will be successful.

Risks

• No assurance that the Transfer Application to The Nasdaq Capital Market will be approved.
• No assurance that the company will be able to regain compliance with Nasdaq listing rules.
• No assurance that the appeal in connection with the hearing will be successful.
• Actual results may differ from expectations due to certain risks and uncertainties.
• The company undertakes no obligation to publicly update forward-looking statements unless required by law.

Future Outlook

The company faces significant uncertainty regarding its continued listing on Nasdaq. While it intends to use reasonable efforts to regain compliance and appeal the delisting determination, there is no assurance that these efforts will be successful or that the transfer application to The Nasdaq Capital Market will be approved.

Management Comments

• "The Company believes that, upon approval of the Transfer Application, it will be better positioned to cure the market value of listed securities deficiency under Nasdaq Listing Rule 5450(b)(2)(A) and the minimum public holders deficiency under Nasdaq Listing Rule 5450(a)(2)."
• "Although the Company will use all reasonable efforts to regain compliance with each of the Nasdaq listing rules, there can be no assurance that the Company will be able to regain compliance with those rules or will otherwise be in compliance with other Nasdaq listing criteria."

Industry Context

StockSavvy.ai notes that delisting notices are a common challenge for Special Purpose Acquisition Companies (SPACs) that either fail to complete a de-SPAC transaction within their specified timeframe or struggle to maintain Nasdaq's stringent listing requirements, particularly regarding market value and public float, post-merger or during their operational phase. This situation highlights the inherent risks associated with SPAC investments, where maintaining exchange compliance is crucial for liquidity and investor confidence.

Legal Proceedings

• The company is appealing Nasdaq's delisting determination before a Nasdaq Hearings Panel.

Stakeholder Impact

• Shareholders: Potential loss of liquidity and significant negative impact on share value if delisting proceeds. Uncertainty regarding the future trading venue and market access.
• Investors: Increased risk and uncertainty regarding the investment's long-term viability on a major exchange.

Next Steps

• The company will present its views at a hearing before a Nasdaq Hearings Panel on March 31, 2026.
• The company will continue to use reasonable efforts to regain compliance with Nasdaq listing rules.

Key Dates

Recommendation

The company faces imminent delisting from Nasdaq, compounded by multiple non-compliance issues including a new deficiency related to publicly held shares. While an appeal is underway, there is no assurance of success, and the transfer to the Nasdaq Capital Market is also uncertain. This situation presents significant risk to shareholder value, liquidity, and the company's ability to attract future capital, warranting a strong sell recommendation for investors to mitigate further potential losses.

Keywords

Bayview Acquisition Corp, BAYA, Nasdaq, delisting, 8-K, SPAC, compliance, listing rules, public float, market value, appeal, corporate governance